DNB Markets, Back Bay Life Science Advisors and KD Pharma
DNB Markets and Back Bay Life Science Advisors (DNB//Back Bay) would like to congratulate O3 Holding GmbH (KD Pharma Group) on a successful EUR 180 million senior secured bond issue.
DNB Markets and Back Bay Life Science Advisors would like to congratulate O3 Holding GmbH (KD Pharma Group) with a successful EUR 180 million senior secured bond issue.
The KD Pharma Group is a CDMO that creates health solutions in the pharmaceutical and nutraceutical space. It is also the worldwide leading producer Omega-3 fatty acids for the pharmaceutical and nutraceutical markets, formulation and encapsulation services, with over 710 employees and a presence in the UK, Norway, Germany, Switzerland, Canada, Peru and the US. The KD Pharma Group employs state-of-the-art technology which is protected by numerous patents.
KD Pharma Group is owned by the German private equity firm capiton AG and dsm-firmenich, a publicly listed global leader in health, nutrition, and beauty.
DNB Markets is pleased to have acted as Sole Manager in connection with the offering.
Herter & Co. – A Teneo Company acted as Debt Advisor to the company.